Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;11(8):4892-4893.
doi: 10.4103/jfmpc.jfmpc_1154_21. Epub 2022 Aug 30.

Pharmacotherapeutics of SARS-CoV-2

Harish Gupta  1 , Nitu Nigam  2 , Satish Kumar  1
Affiliations

Pharmacotherapeutics of SARS-CoV-2

Harish Gupta et al. J Family Med Prim Care. 2022 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Bajpai J, Kant S, Pradhan A, Verma AK. Remdesivir –Current evidence and perspective in management of COVID-19 infection. J Family Med Prim Care. 2021;10:1808–13. - PMC - PubMed
    1. RECOVERY Collaborative Group. Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384:693–704. - PMC - PubMed
    1. Mashal M. A potentially fatal fungal infection is cropping up among India's Covid patients. New York Times May 9. 2021. Available from: https://www.nytimes.com/2021/05/09/world/india-covid-mucormycosis.html .
    1. Moorthy A, Gaikwad R, Krishna S, Hegde R, Tripathi KK, Kale PG, et al. SARS-CoV-2, uncontrolled diabetes and corticosteroids-An unholy trinity in invasive fungal infections of the maxillofacial region?A retrospective, multi-centric analysis. J Maxillofac Oral Surg. 2021:1–8. doi: 10.1007/s12663-021-01532-1. - PMC - PubMed
    1. Gupta H, Nigam N, Verma SK, Kumar S. Mortality data of Covid-19 remain illusive and inconsistent. J Family Med Prim Care. 2020;9:5413–4. - PMC - PubMed